运动性横纹肌溶解症防治进展  

Progress in the Prevention and Treatment of Exertional Rhabdomyolysis

作　　者：刘嘉 赵华昌[1] Liu Jia;Zhao Hua-chang(The Fourth People's Hospital of Chengdu,Chengdu 610000)

机构地区：[1]成都市第四人民医院,成都610000

出　　处：《国外医药（抗生素分册）》2022年第5期342-345,共4页World Notes on Antibiotics

摘　　要：运动性横纹肌溶解症(exertional rhabdomyolysis,ER)是一组与运动相关的,以横纹肌溶解和急性肾损害为主要表现的临床综合征,对人的健康危害大。自1970年由Schrier等报道以来,有许多学者对其进行相关研究。在北京冬季奥运会成功举办后和成都大学生运动会来临之际,全民健身运动达到新的高潮,为指导科学体育锻炼和临床诊疗工作,笔者对ER的概念、病因、发病机制、并发症、临床特征及防治进行综述。Exertional rhabdomyolysis(ER)is a group of exercise-related clinical syndromes characterized by rhabdomyolysis and acute kidney injury.Since it was reported by Schrier et al in 1970,many scholars have carried out relevant studies on it.After the successful holding of the Beijing Winter Olympic Games and before the coming of the Chengdu University Games,the national fitness campaign reached a new climax.In order to guide scientific physical exercise and clinical diagnosis and treatment,the author reviewed the concept,etiology,pathogenesis,complications,clinical characteristics and prevention and treatment of ER.

关 键 词：运动 横纹肌溶解 肌酸激酶 肌红蛋白 急性肾损伤 

分 类 号：R87[医药卫生—运动医学]